Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
National Cancer Institute (NCI)
City of Hope Medical Center
Eli Lilly and Company
GONGCHU Biotechnology Co., Ltd
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Genzada Pharmaceuticals USA, Inc.
MacroGenics
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Altor BioScience
Memorial Sloan Kettering Cancer Center
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Case Comprehensive Cancer Center